UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 1, 2023
Accession Number:
0001193125-23-286282
Submission Type:
POS AM
CIK:
0001604477
Company Name:
SQZ Biotechnologies Co
File Number:
333-260980